Vote Scores

Home / Companies / Agios Pharmaceuticals, Inc. / 18 Jun 2026

Meeting · year to 30 June 2026344 filers reporting

Agios Pharmaceuticals, Inc.: meeting of 18 Jun 2026

Votes reported on Form N-PX, item by item

344 Form N-PX filers reported votes at the Agios Pharmaceuticals, Inc. meeting of 18 Jun 2026. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 85.2% of reported votes for; 40 filers withheld from or voted against at least one nominee.

690 vote records from 113 filers. 12 of the 113 filers that marked the item either way voted against management.

89.4% for0.0% against10.6% other10.6% against management113 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

514 vote records from 342 filers. 24 of the 326 filers that marked the item either way voted against management. 16 filers reported this item without a management mark.

87.1% for6.4% against6.4% other7.4% against management342 filers93.5% for2.4% against4.1% other5.3% against management54,801,573 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

230 vote records from 113 filers. 1 of the 113 filers that marked the item either way voted against management.

99.1% for0.0% against0.9% other0.9% against management113 filers100.0% for0.0% against0.0% other0.0% against management21,148,250 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

237 vote records from 114 filers. 8 of the 114 filers that marked the item either way voted against management.

93.0% for6.1% against0.9% other7.0% against management114 filers96.4% for3.6% against0.0% other3.6% against management21,141,852 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRAbstain or withhold *ForFor
American CenturyForAgainst *For
Franklin TempletonForForFor
InvescoForAgainst *For
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *ForFor
J.P. MorganForForFor
Goldman SachsForForFor
WisdomTreeForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesAbstain or withhold *ForFor
SEIForForFor
T. Rowe PriceAbstain or withhold *ForFor
ThriventForForFor
Lincoln FinancialAbstain or withhold *ForFor
VoyaForForFor
First TrustForForFor
Russell InvestmentsForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalForForFor
Pacific Life fundsForForFor
Global XForForFor
Federated HermesNo reportForNo report
AllianceBernsteinNo reportForNo report
DWSForForFor
AllspringNo reportForNo report
Harbor FundsForForFor
Macquarie and Delaware FundsForForFor
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report
Artisan PartnersNo reportSplit or no voteNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Agios Pharmaceuticals, Inc. meeting?

344 Form N-PX filers reported votes at the meeting of 18 Jun 2026. On say-on-pay, 24 of 326 voted against management (7.4%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Agios Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Agios Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Agios Pharmaceuticals, Inc. with a meeting date within three days of 18 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.